|
1
|
Lloyd RV, Osamura RY, Klöppel G and Rosai
J: WHO Classification of Tumours of Endocrine Organs. 4th Edition.
10. IARC Press; Lyon: 2017
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qian B, He M, Dong S, Wang J and Chen K:
Incidence and mortality of thyroid cancers in Tianjin from 1981 to
2001. Chin J Endocrinol Metab. 21:432–434. 2005.
|
|
4
|
Sosa JA and Udelsman R: Papillary thyroid
cancer. Surg Oncol Clin N Am. 15:585–601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hinson AM, Massoll NA, Jolly LA, Stack BC
Jr, Bodenner DL and Franco AT: Structural alterations in
tumor-draining lymph nodes before papillary thyroid carcinoma
metastasis. Head Neck. 39:1639–1646. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Albores-Saavedra J, Henson DE, Glazer E
and Schwartz AM: Changing patterns in the incidence and survival of
thyroid cancer with follicular phenotype-papillary, follicular, and
anaplastic: A morphological and epidemiological study. Endocr
Pathol. 18:1–7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
LiVolsi VA: Papillary thyroid carcinoma:
An update. Mod Pathol. 24 (Suppl 2):S1–S9. 2011. View Article : Google Scholar
|
|
8
|
Hong IK, Eun YG, Chung DH, Kwon KH and Kim
DY: Association of the oncostatin m receptor gene polymorphisms
with papillary thyroid cancer in the korean population. Clin Exp
Otorhinolaryngol. 4:193–198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ho AS, Luu M, Barrios L, Chen I, Melany M,
Ali N, Patio C, Chen Y, Bose S, Fan X, et al: Incidence and
mortality risk spectrum across aggressive variants of papillary
thyroid carcinoma. JAMA Oncol. 6:706–713. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choden S, Keelawat S, Jung CK and Bychkov
A: VE1 immunohistochemistry improves the limit of genotyping for
detecting BRAFV600E mutation in papillary thyroid
cancer. Cancers (Basel). 12:5962020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Levine AJ, Momand J and Finlay CA: The p53
tumour suppressor gene. Nature. 351:453–456. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
You JS and Jones PA: Cancer genetics and
epigenetics: Two sides of the same coin? Cancer Cell. 22:9–20.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Hou P, Ji M, Guan H, Studeman K,
Jensen K, Vasko V, El-Naggar AK and Xing M: Highly prevalent
genetic alterations in receptor tyrosine kinases and
phosphatidylinositol 3-kinase/akt and mitogen-activated protein
kinase pathways in anaplastic and follicular thyroid cancers. J
Clin Endocrinol Metab. 93:3106–3116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xing M: BRAF mutation in thyroid cancer.
Endocr Relat Cancer. 12:245–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie H, Wei B, Shen H, Gao Y, Wang L and
Liu H: BRAF mutation in papillary thyroid carcinoma (PTC) and its
association with clinicopathological features and systemic
inflammation response index (SIRI). Am J Transl Res. 10:2726–2736.
2018.PubMed/NCBI
|
|
17
|
Salvatore G, Giannini R, Faviana P, Caleo
A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L,
Basolo F and Santoro M: Analysis of BRAF point mutation and RET/PTC
rearrangement refines the fine-needle aspiration diagnosis of
papillary thyroid carcinoma. J Clin Endocrinol Metab. 89:5175–5180.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lian EY, Maritan SM, Cockburn JG, Kasaian
K, Crupi MJ, Hurlbut D, Jones SJ, Wiseman SM and Mulligan LM:
Differential roles of RET isoforms in medullary and papillary
thyroid carcinomas. Endocr Relat Cancer. 24:53–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang Y, Wang X, Xu Y, Yang L, Qian Q, Ju
S, Chen Y, Chen S, Qin N, Ma Z, et al: Comprehensive
characterization of cancer-testis genes in testicular germ cell
tumor. Cancer Med. 8:3511–3519. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Ge Y, Chen X, Wang L, Xia Y and Xu
Z, Li Z, Wang W, Yang L, Zhang D and Xu Z: LEM domain containing 1
promotes proliferation via activating the PI3K/Akt signaling
pathway in gastric cancer. J Cell Biochem. 120:15190–15201. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsuyama H, Suzuki HI, Nishimori H,
Noguchi M, Yao T, Komatsu N, Mano H, Sugimoto K and Miyazono K:
miR-135b mediates NPM-ALK-driven oncogenicity and renders
IL-17-producing immunophenotype to anaplastic large cell lymphoma.
Blood. 118:6881–6892. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takeda R, Hirohashi Y, Shen M, Wang L,
Ogawa T, Murai A, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, et
al: Identification and functional analysis of variants of a
cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
Biochem Biophys Res Commun. 485:651–657. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang K, Singh D, Zeng Z, Coleman SJ, Huang
Y, Savich GL, He X, Mieczkowski P, Grimm SA, Perou CM, et al:
MapSplice: Accurate mapping of RNA-seq reads for splice junction
discovery. Nucleic Acids Res. 38:e1782010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Staveren WC, Solis DW, Delys L, Duprez
L, Andry G, Franc B, Thomas G, Libert F, Dumont JE, Detours V and
Maenhaut C: Human thyroid tumor cell lines derived from different
tumor types present a common dedifferentiated phenotype. Cancer
Res. 67:8113–8120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Georgakopoulos-Soares I, Chartoumpekis DV,
Kyriazopoulou V and Zaravinos A: EMT factors and metabolic pathways
in cancer. Front Oncol. 10:4992020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lundgren CI, Hall P, Dickman PW and
Zedenius J: Clinically significant prognostic factors for
differentiated thyroid carcinoma: A population-based, nested
case-control study. Cancer. 106:524–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kang Y and Massague J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sasahira T, Kurihara M, Nakashima C,
Kirita T and Kuniyasu H: LEM domain containing 1 promotes oral
squamous cell carcinoma invasion and endothelial transmigration. Br
J Cancer. 115:52–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuki D, Lin YM, Fujii Y, Nakamura Y and
Furukawa Y: Isolation of LEM domain-containing 1, a novel
testis-specific gene expressed in colorectal cancers. Oncol Rep.
12:275–280. 2004.PubMed/NCBI
|
|
34
|
Ghafouri-Fard S, Ousati Ashtiani Z, Sabah
Golian B, Hasheminasab SM and Modarressi MH: Expression of two
testis-specific genes, SPATA19 and LEMD1, in prostate cancer. Arch
Med Res. 41:195–200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hirohashi Y, Torigoe T, Tsukahara T,
Kanaseki T, Kochin V and Sato N: Immune responses to human cancer
stem-like cells/cancer-initiating cells. Cancer Sci. 107:12–17.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Najdi R, Proffitt K, Sprowl S, Kaur S, Yu
J, Covey TM, Virshup DM and Waterman ML: A uniform human Wnt
expression library reveals a shared secretory pathway and unique
signaling activities. Differentiation. 84:203–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
